NCT03017287View on ClinicalTrials.gov

Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI

NATerminatedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2017

Study Completion Date

August 31, 2017

Conditions

Diabetes Mellitus, Type 1 or 2

Interventions

DEVICE

GlucoMe App

Assessment of the the GlucoMe App

Trial Locations (1)

Unknown

Diabitic Unit of the Wolfson Medical Center, Holon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

GlucoMe

INDUSTRY

NCT03017287 - Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI | Biotech Hunter | Biotech Hunter